Quality Assurance Research and Development Active Pharmaceutical Ingredients Supply Chain Management Domestic Production Quality Control Generic Drugs Regulatory Affairs Supply Chain National Security Branded Drugs Regulations Global Supply Chain Towa Pharmaceutical Product Development Imports Ibrexafungerp Contamination Production Facilities Damage Plant Recovery Quality Standards Corporate Investments in Healthcare Generic Medicines Tariffs Healthcare Innovation Medicine Production Safety Regulations Biotechnology Supply Chain Disruptions Weight Management Compliance Sterile Injectable Medicines Good Manufacturing Practices Regulatory Processes Supply Disruptions Pain Relief Inspection Backlog Acetaminophen Production Regulatory Environment Drug Pricing Pharmaceutical Companies U.S. Production Global Market Supply Chain Issues Manufacturing Companies Economic Factors Active Ingredients Synthesis Techniques Eli Lilly Zero Gravity Manufacturing Sustainable Practices Chemical Safety Drug Shortages Tariffs on Drugs Regulatory Compliance Weight Loss Drugs
State incentives worth up to $105 million helped secure the site to boost U.S. capacity.
